Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1395 studies found for:    VEGF
Show Display Options
Rank Status Study
1 Unknown  Prospective Randomized Trial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD)
Condition: Exudative Age-related Macular Degeneration
Interventions: Drug: 24GyE proton and Anti-VEGF;   Drug: 16GyE and anti-VEGF;   Drug: Sham Irradiation and anti-VEGF
2 Recruiting Maternal Serum Vascular Endothelial Growth Factor in Pregnant Women With Foetal Growth Restriction
Condition: Foetal Growth Restriction
Interventions: Device: obstetric Ultrasound;   Other: serum Vascular Endothelial Growth Factor
3 Completed
Has Results
Omega-3 Supplementation and Vitreal VEGF Levels in Wet-AMD
Condition: Exudative Age-related Macular Degeneration.
Interventions: Dietary Supplement: Anti-VEGF plus AREDS-2;   Dietary Supplement: Anti-VEGF plus AREDS-1
4 Completed
Has Results
Safety and Efficacy of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Wet Age-Related Macular Degeneration (AMD)
Condition: Macular Degeneration
Intervention: Biological: aflibercept injection (VEGF Trap-Eye, BAY86-5321)
5 Completed Phase 1 Study of VEGF Trap in Patients With Diabetic Macular Edema
Condition: Diabetic Macular Edema
Intervention: Drug: VEGF Trap-Eye
6 Active, not recruiting VEGF Signaling Promotes Cell Growth and Metastasis in Extrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway (ECC)
Condition: Extrahepatic Cholangiocarcinoma
Intervention: Procedure: surgical treatment
7 Recruiting UNcovering the Difference Between Ranibizumab and Aflibercept, Focusing on Systemic Anti-VEGF Effects in Patients With neovascuLar AMD
Condition: Neovacular Age-related Macular Degeneration
Intervention: Procedure: VEGF level assessment
8 Withdrawn Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients
Conditions: Glioma;   Meningioma
Intervention: Procedure: Blood test
9 Enrolling by invitation Vascular Endothelial Growth Factor Levels in Ectopic Pregnancy
Condition: Complication Following Ectopic Pregnancy
10 Completed Angiogenesis Using VEGF-A165/bFGF Plasmid Delivered Percutaneously in No-option CAD Patients; a Controlled Trial
Condition: Coronary Artery Disease
Intervention: Genetic: intramyocardial injection of VEGF-A165/bFGF:placebo plasmid
11 Active, not recruiting Efficacy and Safety of VEGF Trap Eye in Diabetic Macular Edema (DME) With Central Involvement
Condition: Macular Edema
Interventions: Biological: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321);   Procedure: Laser photocoagulation
12 Withdrawn A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.
Conditions: Carcinoma, Renal Cell;   Glioblastoma;   Carcinoma, Hepatocellular
Interventions: Drug: Crizotinib plus VEGF inhibitor combinations;   Drug: Crizotinib plus axitinib;   Drug: Crizotinib plus sunitinib;   Drug: Crizotinib plus bevacizumab;   Drug: Crizotinib plus sorafenib
13 Completed Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD
Condition: Macular Degeneration
Intervention: Drug: VEGF Trap
14 Completed VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer;   Primary Peritoneal Cavity Cancer;   Recurrent Ovarian Epithelial Cancer
Interventions: Drug: docetaxel;   Biological: ziv-aflibercept;   Other: laboratory biomarker analysis;   Other: pharmacological study
15 Recruiting Anterior and Posterior Segment Vascular Changes Following Laser and Anti-Vascular Endothelial Growth Factor (VEGF) Treatment of Diabetic Retinopathy
Condition: Diabetic Macular Edema
16 Completed
Has Results
VEGF Trap in Treating Patients With Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer
Intervention: Biological: ziv-aflibercept
17 Completed
Has Results
Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal Cancer
Condition: Rectal Cancer
Interventions: Drug: Avastin (Bevacizumab, RHUMAB VEGF);   Drug: Capecitabine;   Radiation: Radiation Therapy
18 Withdrawn Does Vascular Endothelial Growth Factor (VEGF) or Complement Factor H Gene Polymorphism Play a Role in the Treatment Success With VEGF Inhibitors in Patients With Choroidal NeoVascularization (CNV)?
Conditions: Choroidal NeoVascularization;   Age-Related Macular Degeneration
Intervention: Genetic: VEGF genotyping
19 Completed
Has Results
Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)
Condition: Macular Edema Secondary to Central Retinal Vein Occlusion
Interventions: Biological: VEGF Trap-Eye 2.0mg;   Drug: Sham
20 Completed Differential Regulation of VEGF, Cadherin, Angiopietin 2 by Trigger Oocyte Maturation With GnRHa vs hCG in Donors
Condition: Messurement Levels of VEGF

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years